These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17555397)

  • 21. Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
    Kollmannsberger C; Bokemeyer C
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):167-72. PubMed ID: 18685416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial.
    Yen Y; Lim DW; Chung V; Morgan RJ; Leong LA; Shibata SI; Wagman LD; Marx H; Chu PG; Longmate JA; Lenz HJ; Ramanathan RK; Belani CP; Gandara DR
    Am J Clin Oncol; 2008 Aug; 31(4):317-22. PubMed ID: 18845988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances with topotecan in the treatment of lung cancer.
    O'Brien M; Eckardt J; Ramlau R
    Oncologist; 2007 Oct; 12(10):1194-204. PubMed ID: 17962613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biological challenges in he treatment of esophageal adenocarcinoma.
    Boonstra JJ; Dinjens WN; Tilanus HW; Koppert LB
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):275-86. PubMed ID: 19072420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of photodynamic therapy in unresectable esophageal and lung cancer.
    Chen M; Pennathur A; Luketich JD
    Lasers Surg Med; 2006 Jun; 38(5):396-402. PubMed ID: 16788924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic therapies for non-metastatic prostate cancer: review of the literature.
    Jereczek-Fossa BA; Curigliano G; Orecchia R
    Onkologie; 2009 Jun; 32(6):359-63. PubMed ID: 19521126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage therapy for Hodgkin's lymphoma.
    Quddus F; Armitage JO
    Cancer J; 2009; 15(2):161-3. PubMed ID: 19390313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EORTC-GU group expert opinion on metastatic renal cell cancer.
    de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
    Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
    Ku GY; Ilson DH
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal cancer: adjuvant therapy.
    Ku GY; Ilson DH
    Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage surgery for esophageal carcinoma after definitive chemoradiation therapy.
    Matsubara H
    Ann Thorac Cardiovasc Surg; 2007 Oct; 13(5):293-5. PubMed ID: 17954984
    [No Abstract]   [Full Text] [Related]  

  • 32. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S; Venner PM; North SA
    Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
    Eichbaum MH; Schuetz F; Khbeis T; Lauschner I; Foerster F; Sohn C; Schneeweiss A
    Anticancer Drugs; 2007 Sep; 18(8):963-8. PubMed ID: 17667603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic cancer: progress in cancer therapy.
    Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
    Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative therapy for esophageal cancer.
    Ku GY; Ilson DH
    Gastroenterol Clin North Am; 2009 Mar; 38(1):135-52, ix. PubMed ID: 19327572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent.
    Lecleire S; Di Fiore F; Antonietti M; Ben-Soussan E; Hochain P; Lerebours E; Michel P; Ducrotté P
    Am J Gastroenterol; 2008 Sep; 103(9):2215-9. PubMed ID: 18844614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [S-1 chemotherapy for cancer of the gastric tube used for esophageal reconstruction following surgery for esophageal cancer].
    Motoyama S; Mori K; Maruyama K; Sato Y; Hayashi K; Usami S; Suzuki H; Ogawa J
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2287-90. PubMed ID: 18079632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoradiation in the management of esophageal cancer.
    Kleinberg L; Forastiere AA
    J Clin Oncol; 2007 Sep; 25(26):4110-7. PubMed ID: 17827461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.